PubMed Health⌕ Search

Biomedical subjects

D Salerno

Publications and source records attributed to D Salerno.

10 recordsLinked to original sources

Quantum-noise-initiated symmetry breaking of spatial solitons.

The spectra of chi(2) spatial solitons are measured close to the soliton-formation threshold and show the presence of sidebands, shifted by 39 THz from the laser line. By comparing with the predictions of a quantum optical field model, solved numerically in the full (3 + 1)-dimensional space, it is claimed that the observed temporal instability of the spatial soliton is seeded by vacuum state fluctuations of the electromagnetic field.

Journal Article↗

Noise-seeded spatiotemporal modulation instability in normal dispersion.

In optical second-harmonic generation with normal dispersion, the virtually infinite bandwidth of the unbounded, hyperbolic, modulational instability leads to quenching of spatial multisoliton formation and to the occurrence of a catastrophic spatiotemporal breakup when an extended beam is left to interact with an extremely weak external noise with a coherence time much shorter than that of the pump.

Journal Article↗

Spatial versus temporal deterministic wave breakup of nonlinearly coupled light waves.

We investigate experimentally the competition between spatial and temporal breakup due to modulational instability in chi((2)) nonlinear mixing. The modulation of the wave packets caused by the energy exchange between fundamental and second-harmonic components is found to be the prevailing trigger mechanism which, according to the relative weight of diffraction and dispersion, leads to the appearance of a multisoliton pattern in the low-dimensional spatial or temporal domain.

Journal Article↗

[Chest pain in adolescents].

In children and in adolescents, chest pain is relatively common and self-limiting. The close association between chest pain, cardiopathies and sudden death is the cause of intense anxiety in boys and their parents and even doctors. The most frequent causes of chest pain, the diagnosis and the eventual treatment are examined. Finally, the causes of chest pain due to drug abuse (in particular cocaine) and to CO poisoning are also examined. Good knowledge of the problem, an accurate anamnesis and a careful objective exam are useful to choose the most suitable treatment.

Adolescent↗

Activity of Procanbid, procainamide twice-daily formulation, to suppress ventricular premature depolarizations. The Study Group Investigators.

Procainamide is a class IA antiarrhythmic drug indicated for the treatment of life-threatening or symptomatic ventricular arrhythmias. The current sustained-release formulation requires 6-hour dosing (qid). To improve patient compliance, a new sustained-release formulation for twice-daily (bid) administration has been developed (Procanbid, Parke-Davis). This study assesses the pharmacologic equivalence of the bid and qid formulations in the suppression of symptomatic ventricular premature depolarizations (VPDs). Fourteen centers enrolled a total of 99 patients with frequent symptomatic VPDs (average > or = 20 VPDs/hr) who previously responded to and tolerated the procainamide qid formulation. During the first week of the double-blind phase, patients were randomized to either placebo or procainamide dosages of 1000, 2000, or 4000 mg/d (bid or qid formulations). In the second week, the patients were crossed over to the alternate formulation. Seventy-seven patients qualified for the primary activity analysis. The bid and qid formulations showed comparable effectiveness in the suppression of mean VPDs with a linear dose-response relationship. The VPD suppression was not attenuated towards the end of the dosing interval for either formulation. Sixty-eight of these patients entered an optional 1-year extension to receive the bid formulation. Thirty-seven (54%) patients had adverse effects. Of those, 15 (22%) had side effects considered treatment related. Most of the adverse events occurred during the first 6 weeks of treatment. Only a few patients (8%) withdrew as a consequence of treatment with the bid formulation. The overall safety profile of the bid formulation was similar to other formulations, and the procainamide bid formulation has a low proarrhythmic rate (< 3%). In conclusion, the effectiveness of the twice-daily formulation of procainamide in the suppression of VPDs is comparable to the currently available qid formulation.

Aged↗

Double-blind placebo-controlled evaluation of propafenone in suppressing ventricular ectopic activity.

The effectiveness of oral propafenone in treating ventricular premature complexes (VPCs) was assessed with a single-blind dose-ranging trial followed by a double-blind, randomized, crossover comparison of propafenone and placebo. Patients subsequently were treated with propafenone for up to 24 months. During dose ranging, the average of individual percent suppressions was 83% at the largest dose (300 mg/8 hours). During the double-blind trial, the effectiveness of propafenone was confirmed, with 7 of 12 patients achieving greater than or equal to 80% reduction in VPCs (p less than 0.05 versus double-blind placebo study). Propafenone was also effective in controlling couplets and nonsustained ventricular tachycardia. Seven patients were treated with propafenone for 24 months, during which effectiveness continued, with mean suppression ranging from 67 to 79% (p less than 0.05 versus initial single-blind placebo). Propafenone prolonged PR and QRS intervals by 16 and 18%, respectively; these prolongations continued during long-term therapy. Propafenone increased serum digoxin levels in 5 of 5 patients (mean increase 83%). Cardiovascular side effects included congestive heart failure (1 patient) and conduction abnormalities (3 patients). Thus, propafenone was effective in the treatment of total and repetitive VPCs. Side effects were few, but congestive heart failure, conduction disturbances and increases in serum digoxin were observed.

Aged↗